DK3846903T3 - Bicykliske heteroarylderivater - Google Patents

Bicykliske heteroarylderivater Download PDF

Info

Publication number
DK3846903T3
DK3846903T3 DK19759411.2T DK19759411T DK3846903T3 DK 3846903 T3 DK3846903 T3 DK 3846903T3 DK 19759411 T DK19759411 T DK 19759411T DK 3846903 T3 DK3846903 T3 DK 3846903T3
Authority
DK
Denmark
Prior art keywords
bicyclic heteroaryl
heteroaryl derivatives
derivatives
bicyclic
heteroaryl
Prior art date
Application number
DK19759411.2T
Other languages
English (en)
Inventor
Hasane Ratni
Jennifer Louise Carter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK3846903T3 publication Critical patent/DK3846903T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK19759411.2T 2018-09-03 2019-09-02 Bicykliske heteroarylderivater DK3846903T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18192219 2018-09-03
PCT/EP2019/073303 WO2020048904A1 (en) 2018-09-03 2019-09-02 Bicyclic heteroaryl derivatives

Publications (1)

Publication Number Publication Date
DK3846903T3 true DK3846903T3 (da) 2024-01-02

Family

ID=63490310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19759411.2T DK3846903T3 (da) 2018-09-03 2019-09-02 Bicykliske heteroarylderivater

Country Status (33)

Country Link
US (1) US12084461B2 (da)
EP (1) EP3846903B1 (da)
JP (1) JP7398435B2 (da)
KR (1) KR102829709B1 (da)
CN (1) CN112566696B (da)
AR (1) AR116051A1 (da)
AU (1) AU2019336492B2 (da)
BR (1) BR112021002170A2 (da)
CA (1) CA3107593A1 (da)
CL (1) CL2021000486A1 (da)
CO (1) CO2021002415A2 (da)
CR (1) CR20210104A (da)
DK (1) DK3846903T3 (da)
ES (1) ES2966947T3 (da)
FI (1) FI3846903T3 (da)
HR (1) HRP20231663T1 (da)
HU (1) HUE064554T2 (da)
IL (1) IL281175B2 (da)
LT (1) LT3846903T (da)
MA (1) MA53541B1 (da)
MX (1) MX2021002087A (da)
MY (1) MY208133A (da)
PE (1) PE20210860A1 (da)
PH (1) PH12021550320A1 (da)
PL (1) PL3846903T3 (da)
PT (1) PT3846903T (da)
RS (1) RS64950B1 (da)
SG (1) SG11202102137SA (da)
SI (1) SI3846903T1 (da)
TW (1) TWI841592B (da)
UA (1) UA128482C2 (da)
WO (1) WO2020048904A1 (da)
ZA (1) ZA202007831B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12275709B2 (en) 2018-12-27 2025-04-15 Hoffmann-La Roche Inc. Process for the preparation of exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamate

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994349A (en) 1997-10-27 1999-11-30 Howard University 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
DK1087934T3 (da) 1998-04-01 2004-06-28 Cardiome Pharma Corp Aminocyclohexyletherforbindelser og anvendelser deraf
WO2000047547A2 (en) 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
WO2000071528A1 (en) 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
WO2001032170A1 (en) 1999-09-13 2001-05-10 Swope David M Composition and method for decreasing neurologic symptomatology
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
WO2007032009A2 (en) 2005-09-15 2007-03-22 Biomas Ltd. Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
KR101138045B1 (ko) 2007-05-11 2012-04-24 에프. 호프만-라 로슈 아게 아밀로이드 베타에 대한 조절제로서의 헤트아릴아닐린
WO2009052126A1 (en) 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE
MX2011005046A (es) 2008-11-13 2011-06-01 Schering Corp Moduladores de gamma secretasa.
CA2753696A1 (en) 2009-02-26 2010-09-02 Noritaka Kitazawa Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
WO2010138901A1 (en) * 2009-05-29 2010-12-02 Biogen Idec Ma Inc Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
WO2011028208A1 (en) 2009-09-04 2011-03-10 Hewlett-Packard Development Company, L.P. Memristors based on mixed-metal-valence compounds
WO2011007756A1 (ja) * 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines
US8703763B2 (en) 2011-03-02 2014-04-22 Hoffmann-La Roche Inc. Bridged piperidine derivatives
TWI567079B (zh) 2011-07-15 2017-01-21 健生醫藥公司 作為伽瑪分泌酶調節劑之新穎的經取代的吲哚衍生物
WO2014060112A1 (en) 2012-10-19 2014-04-24 Origenis Gmbh Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
EP3347363B1 (en) 2015-09-09 2020-01-01 H. Hoffnabb-La Roche Ag N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease
WO2017097728A1 (en) 2015-12-10 2017-06-15 F. Hoffmann-La Roche Ag Bridged piperidine derivatives
CN109311878B (zh) 2016-06-27 2022-05-24 豪夫迈·罗氏有限公司 作为γ-分泌酶调节剂的三唑并吡啶类化合物
AR109829A1 (es) 2016-09-29 2019-01-30 Hoffmann La Roche Derivados de piperidina puenteados
EP3535266B1 (en) * 2016-11-01 2021-12-29 F. Hoffmann-La Roche AG Bicyclic heteroaryl derivatives
AR110122A1 (es) 2016-11-08 2019-02-27 Hoffmann La Roche Fenoxitriazoles
WO2018111926A2 (en) 2016-12-16 2018-06-21 Inception 3, Inc. Methods of treating cochlear synaptopathy
CN111417636B (zh) 2018-01-22 2023-09-26 豪夫迈·罗氏有限公司 三唑并-氮杂䓬衍生物

Also Published As

Publication number Publication date
AR116051A1 (es) 2021-03-25
IL281175A (en) 2021-04-29
LT3846903T (lt) 2024-01-10
CO2021002415A2 (es) 2021-03-08
KR102829709B1 (ko) 2025-07-04
SI3846903T1 (sl) 2024-02-29
PT3846903T (pt) 2023-12-14
US12084461B2 (en) 2024-09-10
IL281175B2 (en) 2024-01-01
WO2020048904A1 (en) 2020-03-12
EP3846903B1 (en) 2023-10-25
US20210323980A1 (en) 2021-10-21
FI3846903T3 (fi) 2023-12-19
RS64950B1 (sr) 2024-01-31
AU2019336492B2 (en) 2024-10-31
AU2019336492A1 (en) 2021-01-07
CN112566696B (zh) 2024-01-16
CL2021000486A1 (es) 2021-07-30
HRP20231663T1 (hr) 2024-03-15
CA3107593A1 (en) 2020-03-12
TWI841592B (zh) 2024-05-11
MA53541B1 (fr) 2024-02-29
KR20210054515A (ko) 2021-05-13
ZA202007831B (en) 2026-03-25
PE20210860A1 (es) 2021-05-18
PL3846903T3 (pl) 2024-05-06
MX2021002087A (es) 2021-04-28
CN112566696A (zh) 2021-03-26
ES2966947T3 (es) 2024-04-25
JP2021535178A (ja) 2021-12-16
JP7398435B2 (ja) 2023-12-14
CR20210104A (es) 2021-04-19
UA128482C2 (uk) 2024-07-24
HUE064554T2 (hu) 2024-03-28
MA53541A (fr) 2021-12-08
TW202023649A (zh) 2020-07-01
PH12021550320A1 (en) 2021-10-04
MY208133A (en) 2025-04-17
IL281175B1 (en) 2023-09-01
SG11202102137SA (en) 2021-04-29
EP3846903A1 (en) 2021-07-14
BR112021002170A2 (pt) 2021-05-04

Similar Documents

Publication Publication Date Title
PL3897842T3 (pl) Pochodne bicykliczne
PT3958977T (pt) Derivados de camptotecina
DK3687999T3 (da) Rapamycinderivater
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
LT3830085T (lt) Deuterinti lanifibranoro dariniai
EP3280707C0 (en) BICYCLIC QUINAZOLINONE DERIVATIVES
PL4013751T3 (pl) Pochodne 2-hydroksycykloalkano-1-karbamoilu
DK3768669T3 (da) Piperazinazaspiroderivater
LT3402792T (lt) Chinolin-2-ono dariniai
LT3457851T (lt) Sobetiromo dariniai
EP4077334C0 (en) FUROINDAZOLE DERIVATIVES
EP4021904C0 (en) ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
PL3898637T3 (pl) Pochodne rapamycyny
EP3884940A4 (en) Novel imidazole derivative
EP3617195A4 (en) NEW TETRAHYDRONAPHTYL UREA DERIVATIVES
EP3663026A4 (en) Lathe
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
EP3885347A4 (en) DIHYDROPYRROLOPYRAZOLE DERIVATIVE
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
PT3796975T (pt) Derivados de sulfonilaminobenzamida
EP3598186C0 (de) Retroreflektor
DK3645513T3 (da) Benzazepinderivater
EP3584023A4 (en) HORIZONTAL TOWER
DK3894410T3 (da) Substituerede xanthinderivater
DK3770162T3 (da) Dihydrochromenderivater